U.S. FDA May Miss MDUFMA Deadline, Industry Sees Progress

International Medical Device Regulatory Monitor
A A
The U.S. device industry and the U.S. Food and Drug Administration (FDA) are closer to an agreement on reauthorizing the Medical Device User Fee and Modernization Act (MDUFMA), but chances are slim that the agency will meet a Jan. 15 goal to deliver that agreement to Congress.

To View This Article:

Login

Subscribe To International Medical Device Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00